Complement gene mutations in children with C3 glomerulopathy: do they affect the response to mycophenolate mofetil?
Neslihan Günayİsmail DursunIbrahim GokceMehtap Akbalik KaraDemet TekcanNeslihan ÇiçekMeral Torun BayramMustafa KoyunNida DinçelHasan DursunSeha Kamil SaygiliZeynep Nagehan Yuruk YildirimSelcuk YukselOsman DönmezSibel YelBeltinge Demircioğlu KılıçÖzlem AydoğBahriye AtmisAysun Çaltık YılmazSevcan A BakkalogluMehmet Baha AytaçMehmet TasdemirBelde Kasap-DemirAlper SoyluElif ÇomakAslı Kantar ÖzşahinAlper KaçarNur CanpolatAlev Yilmazİlknur GirişgenKadirye Betül AkkoyunluHarika AlpayMuammer Hakan PoyrazoğluPublished in: Pediatric nephrology (Berlin, Germany) (2023)
This study is the largest pediatric C3G study examining the relationship between genotype and phenotype. We showed that the mutation group often presented with asymptomatic urinary abnormalities, was diagnosed relatively late but was not different from the without mutation group in terms of MMF treatment response and kidney survival. A higher resolution version of the Graphical abstract is available as Supplementary information.